| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.07 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |